Weight Watchers Adds Compounded Meds
Oct. 8, 2024 WW announced the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight management interventions. The new offering,
Weight Watchers CEO Departs Abruptly
Sept. 27, 2024 WeightWatchers Board member Tara Comonte has been appointed Interim Chief Executive Officer. Ms. Comonte succeeds Sima Sistani, who departs from her role
Lindora Clinics Franchise Is Well Diversified
Sept. 25, 2024 Lindora Clinics, a regional medical weight loss chain based in California, has recently begun franchising. As such, it has filed a 2024
Weight Loss Market’s Leaders Lost At Least $971 Million in 2023
Sept. 24, 2024 Marketdata LLC, DietBusinessWatch.com’s parent), estimates that the top competitors in the U.S. weight loss market lost at least $971 million in revenues
GLP-1 Drugs Market Update
Sept. 23, 2024 According to Becker’s Hospital Review… On Sept. 24, Novo Nordisk CEO Lars Fruergaard Jørgensen is slated to testify at a Senate committee
Lindora Clinics Now Selling Franchises
Sept. 19, 2024 Lindora Clinics, a long-time competitor in the medical weight loss market, has begun selling franchises. The firm has 31 sites, focused on
Noom Offers Compounded Weight Loss Drugs
Sept. 12, 2024 Noom is the latest weight loss company to start prescribing compounded versions of the obesity medication semaglutide. This follows similar moves by
Study finds that 42% of online pharmacies selling semaglutide are illegal
August 14, 2024 Nearly half of online pharmacies that sell semaglutide — the active ingredient in Ozempic and Wegovy — are doing so illegally, posing